Literature DB >> 15678123

MRI reveals that early changes in cerebral blood volume precede blood-brain barrier breakdown and overt pathology in MS-like lesions in rat brain.

Kerry A Broom1, Daniel C Anthony, Andrew M Blamire, Sara Waters, Peter Styles, Victor Hugh Perry, Nicola R Sibson.   

Abstract

Magnetic resonance imaging (MRI) is an established clinical tool for diagnosing multiple sclerosis (MS), the archetypal central nervous system neuroinflammatory disease. In this study, we have used a model of delayed-type hypersensitivity in the rat brain, which bears many of the hallmarks of an MS lesion, to investigate the development of MRI-detectable changes before the appearance of conventional indices of lesion development. In addition, we have correlated the MRI-detectable changes with the developing histopathology. Significant increases in regional cerebral blood volume (rCBV) preceded overt changes in blood-brain barrier (BBB) permeability, T2 relaxation and the diffusion properties of tissue water. Thus, changes in rCBV might be a more sensitive indicator of lesion onset than the conventional indices used clinically in MS patients, such as contrast enhancement. In addition, we show that BBB breakdown, and consequent edema formation, are more closely correlated with astrogliosis than any other histopathologic changes, while regions of T1 and T2 hypointensity appear to reflect hypercellularity.

Entities:  

Mesh:

Year:  2005        PMID: 15678123     DOI: 10.1038/sj.jcbfm.9600020

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  18 in total

1.  Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain.

Authors:  Matthew D Budde; Eric Gold; E Kay Jordan; Melissa Smith-Brown; Joseph A Frank
Journal:  NMR Biomed       Date:  2011-09-22       Impact factor: 4.044

2.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

3.  Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability.

Authors:  David Paling; Esben Thade Petersen; Daniel J Tozer; Daniel R Altmann; Claudia A M Wheeler-Kingshott; Raju Kapoor; David H Miller; Xavier Golay
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-18       Impact factor: 6.200

4.  Diffusion fMRI detects white-matter dysfunction in mice with acute optic neuritis.

Authors:  Tsen-Hsuan Lin; William M Spees; Chia-Wen Chiang; Kathryn Trinkaus; Anne H Cross; Sheng-Kwei Song
Journal:  Neurobiol Dis       Date:  2014-03-13       Impact factor: 5.996

5.  Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats.

Authors:  Simon Nagel; Michalis Papadakis; Ruoli Chen; Lisa C Hoyte; Keith J Brooks; Daniel Gallichan; Nicola R Sibson; Chris Pugh; Alastair M Buchan
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-21       Impact factor: 6.200

6.  Characterizing brain oxygen metabolism in patients with multiple sclerosis with T2-relaxation-under-spin-tagging MRI.

Authors:  Yulin Ge; Zhongwei Zhang; Hanzhang Lu; Lin Tang; Hina Jaggi; Joseph Herbert; James S Babb; Henry Rusinek; Robert I Grossman
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-18       Impact factor: 6.200

7.  The role of dietary antioxidant insufficiency on the permeability of the blood-brain barrier.

Authors:  Hussni O Mohammed; Simon R Starkey; Korona Stipetic; Thomas J Divers; Brian A Summers; Alexander de Lahunta
Journal:  J Neuropathol Exp Neurol       Date:  2008-12       Impact factor: 3.685

8.  Cerebral blood volume affects blood-brain barrier integrity in an acute transient stroke model.

Authors:  Shuning Huang; Jeong Kon Kim; Dmitriy N Atochin; Christian T Farrar; Paul L Huang; Ji Yeon Suh; Seon Joo Kwon; Woo Hyun Shim; Hyungjoon Cho; Gyunggoo Cho; Young Ro Kim
Journal:  J Cereb Blood Flow Metab       Date:  2013-03-06       Impact factor: 6.200

9.  The blood-brain barrier and microvascular water exchange in Alzheimer's disease.

Authors:  Valerie C Anderson; David P Lenar; Joseph F Quinn; William D Rooney
Journal:  Cardiovasc Psychiatry Neurol       Date:  2011-05-04

10.  Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.

Authors:  Sébastien Serres; Claire Bristow; Rocío M de Pablos; Doron Merkler; Manuel Sarmiento Soto; Nicola R Sibson; Daniel C Anthony
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-20       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.